Effectiveness of Small Phlebotomy Tubes in Reducing Blood Transfusions in Adult Medical Intensive Care Unit and Intermediate Care Unit Patients With Anemia
Part of paid clinical trials in Houston, Texas.
- Sponsor
- The University of Texas Health Science Center, Houston
- Study ID
- NCT05750654
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Small Phlebotomy Tube Group — DEVICEIn the small tubes group, the recommended blood volumes are 0.5 mL for hematology and single chemistry tests, and 1 mL when multiple chemistry tests are needed. A, a "non-formulary medication" order will be placed in the electronic medical record to alert nurses to collect blood in small tubes. Participants will continue to use small tubes anytime they are in the ICU or IMU.
- Standard Phlebotomy Tube Group — DEVICEIn the standard tubes group, the recommended blood volumes are 4.0 mL for hematology and 3.0 for chemistry tests.
Study Details
The purpose of this study is to evaluate the effectiveness of small phlebotomy tubes to reduce RBC transfusions in medical intensive care unit (ICU) and Intermediate care unit (IMU) patients with low hemoglobin compared with standard size tubes, to compare the intervention and the control groups in regards to: ICU length of stay (LOS), ICU mortality, hospital LOS, and hospital mortality and to assess the acceptability of small phlebotomy tubes in adult ICU and IMU patients.
Key Dates
- Start date
- Jul 24, 2023
- Status verified
- Aug 2025
- Primary completion
- Jan 31, 2026
- Completion
- Jan 31, 2026
Study Design
- Enrollment
- 688 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: Small Tube Group
- Active Comparator: Standard Tube Group
Primary Outcome Measure
Number of participants that receive a red blood cell (RBC) transfusion during hospitalization [ Time Frame: up to 30 days after randomization ]
Central Contacts
- Javier Barreda Garcia, MD713-500-6828
- Ibilola A Sanusi, MD713-486-6153
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 |
Find similar trials in Houston, TX
Related Studies
- Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and AnemiaPHASE1/PHASE2 · Recruiting · Disc Medicine, Inc · Duarte, California
- A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and EfficiencyRecruiting · The University of Texas Health Science Center, Houston · Houston, Texas
- Study of DISC-0974-201 in Participants With IBD and AnemiaPHASE2 · Recruiting · Disc Medicine, Inc · Scottsdale, Arizona
- A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood TransfusionsPHASE3 · Recruiting · Takeda · Orange, California